Name the SKU and the fill on the requisition
VaultLabs catalogues the single-sequence material as GLP-3 RT at two fills: 10 mg and 20 mg. A requisition that says "retatrutide" without a fill is incomplete, because the stock-solution arithmetic in a protocol written against one fill does not survive substitution with the other, and the person preparing the stock is usually not the person who raised the order.
RETA/CAG 15 mg is a separate line and not an alternative format. It is a combination presentation with its own identity, its own lots and its own certificates — see the RETA/CAG monograph and the side-by-side comparison. Substituting it against a single-sequence requisition is an identity change, not a packaging change.
Confusion with other incretin-class catalogue names is common enough to be worth heading off at the requisition stage rather than at goods-in. Retatrutide versus semaglutide and retatrutide versus tirzepatide exist to settle which SKU is meant; the identity mapping article covers how the mix-up happens on purchase orders.
Investigational status changes the paperwork, not just the label
Retatrutide is an investigational compound. It is not approved as a medicine by the UAE Ministry of Health and Prevention, the FDA, the EMA or any comparable regulator, and there is no route by which research material becomes something a person may use.
For an institution this has a practical consequence. Compounds with high public interest attract more scrutiny during internal review, so the research-use basis should be documented at the point of order rather than reconstructed later. VaultLabs records a research-use declaration with the order and states the scope in the research use policy; regulatory orientation and official UAE sources are collected in the regulatory overview.
Laboratories should also consider whether intellectual-property or publication constraints apply to their own work, given that the compound is under active investigation by its originator. That question belongs to your institution, not to a supplier.
Receiving a long peptide
This is a large molecule by catalogue standards — several times the mass of a short research peptide — and size changes what a receiving check should look for. Deletion and truncation variants in long sequences are not reliably resolved by chromatography alone, so where a laboratory has mass spectrometry available, an incoming-goods confirmation carries more weight here than it would for a short peptide. The mass spectrometry primer covers why.
Handle the material gently at the point of preparation. Long peptides are prone to aggregation under vigorous agitation, and a preparation that has aggregated is not recoverable by noticing it afterwards. Record the diluent, the preparation date and each thaw cycle; the certified figure describes the lyophilised lot at release and does not extend to a solution held over time.
Verify the lot in the usual way. Batch verification and the GLP-3 RT certificate index resolve published records, and the retatrutide COA verification walkthrough is the step-by-step version for this SKU.
Storage and the UAE receiving interval
Sealed vials are specified cold, protected from light and moisture, per the product page and the lot certificate. The compound-specific notes are on the retatrutide storage guide; the regional reasoning about receiving windows is in the UAE climate storage guide.
The weak point is the same as for everything else in this catalogue: the unmanaged interval between a courier signature and monitored cold storage. Arrange for someone to be present, log arrival time and packaging condition, and let sealed units equilibrate before opening so humid air does not condense onto the cake.
Format questions that come from the consumer market — vials against pre-filled devices, for instance — are addressed at vial versus pen formats. VaultLabs supplies lyophilised research vials; the comparison exists because the question is asked, not because the alternatives are equivalent.
What this page does not provide
No preparation guidance for people or animals, no protocols, no outcome discussion. VaultLabs makes no claims about what this compound does in a living system and declines orders that indicate an intended human use.
Ordering context, AED pricing and emirate dispatch detail sit on the retatrutide research peptide UAE page. The material is supplied as an in vitro laboratory research reference only.






